StemSIGHT - Vision unlimited

Delivery of human limbal stem cells for sustained renewal of corneal epithelium


Limbal stem cell deficiency (LSCD) is a blinding disease, where the natural renewal capacity of the cornea is lost. This painful and debilitating condition can result from thermal or chemical burns or severe infections, and affects millions of people worldwide. Currently no valid treatment exists for patients suffering from LSCD in both eyes.

StemSIGHT offers a standardized treatment for these patients with the help of highly potent limbal epithelial cells obtained from human pluripotent stem cells. These cells are transplanted to the eye on a biodegradable carrier material.